Monday, November 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Aurubis Stock: Surges on Upgraded Outlook

Robert Sasse by Robert Sasse
August 5, 2025
in Stocks
0
Aurubis Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Aurubis shares jumped over 3% to €89.35 on Tuesday, ranking among the top performers in the MDAX, as the copper producer exceeded quarterly expectations and narrowed its annual forecast. While operating profit before taxes fell 37% to €57 million in Q3 due to planned maintenance shutdowns in Bulgaria and Lünen, investors focused on the bigger picture. The modernization of Aurubis’s Bulgarian plant—its largest investment in 30 years—cost €115 million but positions the company for long-term growth. Nine-month operating profit reached €286 million, surpassing analyst estimates, prompting management to tighten its full-year guidance to €330–370 million (from €300–400 million).

US Expansion Weighs on Short-Term Results

The newly opened $740 million recycling plant in Georgia is currently denting earnings, with profitability expected only by 2026/27. However, the move hedges against potential trade tariffs and taps into America’s recycling boom. Higher copper and gold prices, alongside strong sulfuric acid sales, offset some headwinds, though supply chain constraints for copper concentrates persist. Despite a 20% drop in net profit to €215 million over nine months, Aurubis shares have gained 17% this year, reflecting investor confidence in its strategic investments.

Ad

Aurubis Stock: Buy or Sell?! New Aurubis Analysis from November 10 delivers the answer:

The latest Aurubis figures speak for themselves: Urgent action needed for Aurubis investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 10.

Aurubis: Buy or sell? Read more here...

Tags: Aurubis
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Spotify Stock

Spotify Stock: Price Hike Sparks Investor Cheer

Rational Stock

Rational Stock: Mixed Outlook Amid Tariff Pressures

Mazda Motor Stock

Mazda Motor Stock: Profit Plunge Amid US Tariff Woes

Recommended

Marvell Technology Stock

Marvell Technology Shares Plunge Despite Record Quarterly Performance

2 months ago
Finance_Credit

Zenvia Inc Makes Strides in Financial Needs and Provides Guidance for 2024

2 years ago
BMY stock news

Barclays downgrades Diageo’s target price: Uncertainty lies ahead for iconic beverage company

2 years ago
IonQ Stock

Quantum Computing Stock Slips Despite Strategic Board Appointment

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Snowflake Stock Soars as AI Demand Fuels Remarkable Rally

Marsh McLennan Shares Face Uphill Battle Amid Sector Headwinds

Leadership Turmoil Compounds Synopsys’ Mounting Challenges

Stride Faces Investor Backlash Following Platform Failure

Lockheed Martin Shares Face Market Pressure Despite Strong Performance

Arthur J Gallagher: A Stock at a Crossroads

Trending

The Trade Desk Stock
Analysis

Strong Earnings Report Fails to Prevent The Trade Desk Share Slide

by Robert Sasse
November 10, 2025
0

Investors delivered a harsh verdict on The Trade Desk's latest financial results, sending shares sharply lower despite...

Bristol-Myers Squibb Stock

Is Bristol-Myers Squibb Stock Mounting a Sustained Recovery?

November 10, 2025
Msci Stock

MSCI Capitalizes on Surging ESG and Index Market Trends

November 10, 2025
Snowflake Stock

Snowflake Stock Soars as AI Demand Fuels Remarkable Rally

November 10, 2025
Marsh McLennan Stock

Marsh McLennan Shares Face Uphill Battle Amid Sector Headwinds

November 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Strong Earnings Report Fails to Prevent The Trade Desk Share Slide
  • Is Bristol-Myers Squibb Stock Mounting a Sustained Recovery?
  • MSCI Capitalizes on Surging ESG and Index Market Trends

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com